Condition
Myotonic Dystrophy Type 2
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05854433RecruitingPrimary
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2
NCT00082108Recruiting
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
NCT04907162Completed
Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders
NCT03603171CompletedPrimary
Clinical Outcome Measures in Myotonic Dystrophy Type 2
NCT03211923Unknown
Muscle Relaxation in Myopathies With Positive Muscle Phenomena
Showing all 5 trials